Genetic variants of human UGT1A3: Functional characterization and frequency distribution in a Chinese Han population

被引:43
作者
Chen, Yakun [1 ]
Chen, Shuqing [1 ]
Li, Xin [1 ]
Wang, Xiewei [1 ]
Zeng, Su [1 ]
机构
[1] Zhejiang Univ, Dept Drug Metab & Pharmaceut Anal, Coll Pharmaceut Sci, Hangzhou 310031, Peoples R China
关键词
D O I
10.1124/dmd.106.009761
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
UDP-glucuronosyltransferase 1A3 (UGT1A3) contributes to glucuronidation of many important endogenous compounds and xenobiotics, including some flavonoids. Recently, a total of six single nucleotide polymorphisms ( SNPs) have been identified in the human UGT1A3 gene. Among them, four SNPs (A17G, Q(6)R; T31C, (WR)-R-11; C133T, (RW)-W-45; and T140C, V(47)A) cause amino acid substitutions. Variants caused by these SNPs showed an activity change in estrone metabolism, whereas their activities toward other substrates were not examined. In the present study, three common flavonoids, quercetin, luteolin, and kaempferol, were used as substrates for glucuronidation by wild-type and variant UGT1A3s. Our results demonstrated that the activities of three variants, UGT1A3.2, UGT1A3.3, and UGT1A3.5, were remarkably lower than that of UGT1A3.1. In contrast, UGT1A3.4 exhibited an increase in glucuronidation efficiency of approximately 4 times and a clear preference to quercetin 7- and 3-hydroxyl groups. The frequency distributions of UGT1A3 alleles and SNPs in UGT1A3 in a Chinese Han population were statistically different from the reported value in German-Caucasians ( p < 0.05). UGT1A3 variants have an altered glucuronidation activity toward quercetin, luteolin, and kaempferol and may alter human susceptibility to flavonoid exposure.
引用
收藏
页码:1462 / 1467
页数:6
相关论文
共 40 条
[1]   Genetic polymorphism of UDP-glucuronosyltransferase 2B7 (UGT2B7) at amino acid 268: ethnic diversity of alleles and potential clinical significance [J].
Bhasker, CR ;
McKinnon, W ;
Stone, A ;
Lo, ACT ;
Kubota, T ;
Ishizaki, T ;
Miners, JO .
PHARMACOGENETICS, 2000, 10 (08) :679-685
[2]  
BOSMA PJ, 1994, J BIOL CHEM, V269, P17960
[3]   THE GENETIC-BASIS OF THE REDUCED EXPRESSION OF BILIRUBIN UDP-GLUCURONOSYLTRANSFERASE-1 IN GILBERTS-SYNDROME [J].
BOSMA, PJ ;
CHOWDHURY, JR ;
BAKKER, C ;
GANTLA, S ;
DEBOER, A ;
OOSTRA, BA ;
LINDHOUT, D ;
TYTGAT, GNJ ;
JANSEN, PLM ;
ELFERINK, RPJO ;
CHOWDHURY, NR .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (18) :1171-1175
[4]  
Carlini LE, 2005, CLIN CANCER RES, V11, P1226
[5]   Heterologous expression of active human uridine diphosphate glucuronosyltransferase 1A3 in Chinese hamster lung cells [J].
Chen, Ya-Kun ;
Li, Xin ;
Chen, Shu-Qing ;
Zeng, Su .
WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (01) :118-121
[6]   Quantitative regioselectivity of glucuronidation of quercetin by recombinant UDP-glucuronosyltransferases 1A9 and 1A3 using enzymatic kinetic parameters [J].
Chen, YK ;
Chen, SQ ;
Li, X ;
Zeng, S .
XENOBIOTICA, 2005, 35 (10-11) :943-954
[7]   Effect of the UGT2B15 genotype on the pharmacokinetics, pharmacodynamics, and drug interactions of intravenous lorazepam in healthy volunteers [J].
Chung, JY ;
Cho, JY ;
Yu, KS ;
Kim, JR ;
Jung, HR ;
Lim, KS ;
Jang, IJ ;
Shin, SG .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (06) :486-494
[8]   Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications [J].
Ciotti, M ;
Marrone, A ;
Potter, C ;
Owens, IS .
PHARMACOGENETICS, 1997, 7 (06) :485-495
[9]   Quercetin metabolites inhibit copper ion-induced lipid peroxidation in rat plasma [J].
da Silva, EL ;
Piskula, MK ;
Yamamoto, N ;
Moon, JH ;
Terao, J .
FEBS LETTERS, 1998, 430 (03) :405-408
[10]   Variation of hepatic glucuronidation:: Novel functional polymorphisms of the UDP-glucuronosyltransferase UGT1A4 [J].
Ehmer, U ;
Vogel, A ;
Schütte, JK ;
Krone, B ;
Manns, MP ;
Strassburg, CP .
HEPATOLOGY, 2004, 39 (04) :970-977